NR 507 Week 3 Edapt Practice Questions; Respiratory System
Document Preview
Unlock Full 19 Page Document Instantly.
Document Overview
What is the primary mechanism by which chronic exposure to irritants leads to the pathogenesis of emphysema? A) Increased production of surfactant B) Inflammation of airway epithelium and release of inflammatory mediators C) Decreased elasticity of the alveolar walls D) Hypertrophy of the diaphragm Correct Answer: B) Inflammation of airway epithelium and release of inflammatory mediators Which of the following is the most common genetic risk factor associated with chronic obstructive pulmonary disease (COPD)? A) Cystic fibrosis B) Alpha-1-antitrypsin deficiency (AATD) C) Bronchial asthma D) Pulmonary fibrosis Correct Answer: B) Alpha-1-antitrypsin deficiency (AATD) In the context of pulmonary function tests (PFTs), what does a post-bronchodilator FEV1/FVC ratio of less than 0.7 indicate? A) Normal lung function B) Restrictive lung disease C) Obstructive lung disease D) Hyperinflation Correct Answer: C) Obstructive lung disease Which of the following statements about the FEV1/FVC ratio is true? A) A ratio greater than 70% indicates obstructive lung disease. B) A ratio less than 70% indicates restrictive lung disease. C) A normal ratio is indicative of normal lung function regardless of FEV1 values. D) A decrease in the FEV1/FVC ratio is a hallmark of obstructive lung disease. Correct Answer: D) A decrease in the FEV1/FVC ratio is a hallmark of obstructive lung disease. What is a common complication of chronic obstructive pulmonary disease (COPD) due to impaired gas exchange? A) Hypertension B) Pneumonia C) Diabetes D) Osteoporosis Correct Answer: B) Pneumonia Which of the following is NOT a recommended prevention strategy for reducing exacerbations in patients with COPD? A) Smoking cessation B) Regular vaccinations C) Avoiding air pollutants D) Increased exposure to respiratory irritants Correct Answer: D) Increased exposure to respiratory irritants In the management of COPD, which pharmacological treatment is recommended for a patient experiencing two or more exacerbations per year? A) Short-acting beta-agonists (SABAs) B) Long-acting beta-2 agonists (LABAs) and long-acting muscarinic antagonists (LAMAs) C) Inhaled corticosteroids (ICS) D) Oral corticosteroids Correct Answer: B) Long-acting beta-2 agonists (LABAs) and long-acting muscarinic antagonists (LAMAs) **What process occurs during alveolar gas exchange?** Oxygen diffuses into the alveoli Carbon dioxide diffuses into the blood Oxygen diffuses into the bloodstream Carbon dioxide is produced **Answer:** C) Oxygen diffuses into the bloodstream **What drives the gas exchange process in the alveoli?** Temperature differences Partial pressure differences Blood flow velocity Airway obstruction **Answer:** B) Partial pressure differences **In obstructive pulmonary disease, what is typically decreased?** FEV1/FVC ratio Lung volume Total lung capacity Inspiratory reserve volume **Answer:** A) FEV1/FVC ratio **What indicates a restrictive pulmonary disease?** Low FEV1 and low FEV1/FVC ratio Normal FEV1/FVC ratio with reduced lung volume Normal FEV1 and FVC Airway obstruction **Answer:** B) Normal FEV1/FVC ratio with reduced lung volume **What is a common symptom of COPD?** Fever Decreased FEV1 Increased FVC Normal breathing rate **Answer:** B) Decreased FEV1 **Which of the following is associated with asthma?** Airway dilation Increased mucus production Gas exchange improvement Decreased airway resistance **Answer:** B) Increased mucus production **Which symptom is NOT typically associated with asthma?** Wheezing Chest tightness Weight gain Coughing
Full content available after purchase or with an active subscription.
Related Products
Related Products
Academic Use Notice: This resource is provided strictly as study support material to help students review concepts, understand topic structure, and prepare their own original academic work responsibly. It is not intended to be submitted directly as a student's own work.